Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration

Ternant, D; Passot, C; Aubourg, A; Goupille, P; Desvignes, C; Picon, L; Lecomte, T; Mulleman, D; Paintaud, G

Ternant, D (reprint author), Univ Francois Rabelais Tours, Lab Pharmacol Toxicol, CNRS, CHRU Tours,UMR 7292, 2 Blvd Tonnelle, F-37044 Tours, France.; Ternant, D (reprint author), CHRU Tours, Lab Pharmacol Toxicol, Tours, France.

CLINICAL PHARMACOKINETICS, 2018; 57 (9): 1173

Abstract

The pharmacokinetics of infliximab are highly variable and influence clinical response in chronic inflammatory diseases. The goal of this study was to......

Full Text Link